Pharmacokinetics and Tissue Distribution of Iv Injection of Polyphase Liposome-encapsulated Cisplatin (KM-1) in Rats

Overview

Journal Acta Pharmacol Sin

Specialty Pharmacology

Date 2003 Jun 7

PMID 12791187

Citations 4

Authors

Shan Wang

Jie-Bo Mi

Yuan-Zong Li

Wen-Bao Chang

Yun-Xiang Ci

Min-Zheng Zhao

Yun-Kun Zhao

Li-Ya Zhu

Guang Xu

Affiliations

Soon will be listed here.

Abstract

Aim: The pharmacokinetics and biodistribution of cisplatin encapsulated in polyphase liposome (KM-1) were compared with those of free drug in rats.

Methods: The platinum levels in serum and normal organs, after a single dose of iv injection of free or encapsulated cisplatin to rats, were determined by induced coupled plasma atomic emission spectrometry.

Results: Serum platinum concentration-time curve after a single iv dose of KM-1 4.5 mg/kg in rats was fitted with an open three-compartment model. The pharmacokinetic parameters were as follows: Vc=0.10 L/kg, T1/2pai=0.3 h, T1/2alpha=3.5 h, T1/2beta=2.7 h, AUC=265 mg.h.L(-1), and CL(s) =0.02 g.L.h(-1). KM-1 was cleared from the circulation much more slowly than free cisplatin. Liver and spleen had the highest concentration of platinum after KM-1 treatment.

Conclusion: KM-1 remained in the bloodstream longer than its free drug, and was taken mainly by the reticuloendothelial system.

Citing Articles

Potent Small-Molecule Inhibitors Targeting Acetylated Microtubules as Anticancer Agents Against Triple-Negative Breast Cancer.

Kwon A, Lee G, Park T, Lee J, Ko P, You E Biomedicines. 2020; 8(9).

PMID: 32917017 PMC: 7555225. DOI: 10.3390/biomedicines8090338.

Liposomes Loaded with Cisplatin and Magnetic Nanoparticles: Physicochemical Characterization, Pharmacokinetics, and In-Vitro Efficacy.

Toro-Cordova A, Flores-Cruz M, Santoyo-Salazar J, Carrillo-Nava E, Jurado R, Figueroa-Rodriguez P Molecules. 2018; 23(9).

PMID: 30200551 PMC: 6225157. DOI: 10.3390/molecules23092272.

Antitumor activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer.

Muscella A, Vetrugno C, Migoni D, Biagioni F, Fanizzi F, Fornai F Cell Death Dis. 2014; 5:e1014.

PMID: 24457958 PMC: 4040677. DOI: 10.1038/cddis.2013.554.

Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo.

Dhar S, Kolishetti N, Lippard S, Farokhzad O Proc Natl Acad Sci U S A. 2011; 108(5):1850-5.

PMID: 21233423 PMC: 3033286. DOI: 10.1073/pnas.1011379108.